Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Hypertension. 2019 Dec 2;75(1):193–201. doi: 10.1161/HYPERTENSIONAHA.119.13368

Table 1.

Maternal Characteristics of Polypeptide – Treated Rats in the Placental Ischemia Model.

Metrics Sham
Saline
RUPP
Saline
Sham
SynB1
-ELP
(50
mg/kg/
d)
RUPP
SynB1
-ELP
(50
mg/kg
/d)
Sham
Free
p50i
(2
mg/k
g/d)
RUPP
Free
p50i
(2
mg/kg/
d)
Sham
SynB1
-ELP-
p50i
(50
mg/kg
/d)
RUPP
SynB1
-ELP-
p50i
(50
mg/kg
/d)
Sham
SynB1
-ELP-
p50i
(75
mg/kg
/d)
RUPP
SynB1
-ELP-
p50i
(75
mg/kg
/d)
Maternal Body Weight (g) 291 ± 23 262 ± 15* 281 ± 13 263 ± 12 297 ± 16 264 ± 25* 301 ± 10 271 ± 19* 293 ± 21 266 ± 22*
Maternal MAP (mmHg) 100 ± 13 120 ± 11* 99 ± 10 123 ± 6* 103 ± 10 115 ± 9 98 ± 9 111 ± 5 92 ± 12 112 ± 10*
Maternal Heart Weight (g) 0.77 ± 0.10 0.82 ± 0.10 0.71 ± 0.04 0.72 ± 0.08 0.79 ± 0.04 0.76 ± 0.05 0.75 ± 0.08 0.80 ± 0.08 0.77 ± 0.12 0.86 ± 0.11
Maternal Kidney Weight (g) 0.81 ± 0.09 0.85 ± 0.09 0.76 ± 0.08 0.84 ± 0.08 0.81 ± 0.07 0.81 ± 0.10 0.77 ± 0.09 0.82 ± 0.1 0.80 ± 0.08 0.87 ± 0.1*
Total Litter Size (GD14, pre-surgery) 11.3 ± 1.8 11.8 ± 1.5 10.7 ± 0.9 11.1 ± 1.5 11.3 ± 1.0 11.7 ± 1.2 11.4 ± 1.6 12.0 ± 1.5 10.7 ± 1.5 12.1 ± 1.8
Reabsorption Rate (%) 5.9 ± 10.1 69.5 ± 14.2* 17.5 ± 18.8 76.7 ± 16.2* 9.7 ± 10.2 66.6 ± 11.7* 4.8 ± 7.3 70.8 ± 18.9* 12.6 ± 20.1 68.3 ± 18.4*
Placental Weight (g) 0.62 ± 0.05 0.59 ± 0.07 0.59 ± 0.09 0.53 ± 0.09 0.63 ± 0.04 0.53 ± 0.07 0.55 ± 0.06 0.55 ± 0.12 0.62 ± 0.06 0.60 ± 0.10
Fetal Weight (g) 2.56 ± 0.20 2.43 ± 0.20 2.51 ± 0.29 2.24 ± 0.28 2.57 ± 0.32 2.22 ± 0.28 2.47 ± 0.15 2.33 ± 0.20 2.55 ± 0.19 2.46 ± 0.25
Placental Efficiency 4.15 ± 0.40 4.16 ± 0.59 4.27 ± 0.51 4.32 ± 0.76 4.10 ± 0.32 4.20 ± 0.55 4.54 ± 0.45 4.35 ± 0.78 4.14 ± 0.26 4.17 ± 0.61

Mean ± SD are shown.

*

Statically significant difference between Sham and RUPP operated rats with the same test agent treatment were assessed using a two-way ANOVA with post-hoc Tukey’s multiple comparison of all groups pair-wise.